Current and promising methods of idiopathic male infertility treatment

Author:

Efremov E. A.1ORCID,Kasatonova E. V.2ORCID

Affiliation:

1. N. I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; International Center of Andrology

2. N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Center of Radiology, Ministry of Health of Russia

Abstract

For a significant number of couples around the world, male infertility is a serious ordeal. The truth is that this is also a major clinical challenge for the andrologist – up to 50 % of men with infertility have no identifiable etiology and there is no effective, available evidence-based treatment. For a long time, antioxidant supplements have been used as empiric therapy, but there is still no conclusive evidence that fertility and live birth rates actually improve after this approach has been used. This review is an attempt to summarize current and prospective treatments for idiopathic male infertility. Particular attention is paid to regulatory peptides as promising candidates for improving male fertility.

Publisher

Publishing House ABV Press

Subject

Urology,Reproductive Medicine,Surgery

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. What should urologist know about sperm DNA fragmentation;Andrology and Genital Surgery;2023-03-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3